Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, representing a newer version of the page. It is a metadata/version update and does not reflect a substantive change to study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedUpdates the ClinicalTrials.gov page “Revision” from v3.5.2 to v3.5.3, reflecting a platform/version release rather than any change to the underlying study record.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no study details or outcomes appear to be affected.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.4.2 was added, and the funding-status notice (and Revision: v3.4.1) were removed. These are administrative site updates and do not affect the trial details or eligibility information presented on the page.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.